FASN and breast carcinoma: As for breast cancer progression specifically, several studies show that fatty acid synthase (FASN) inhibition decreases proliferation and increases the chemosensitivity of many breast cancer cell lines as well as in experimental breast cancer models [22,23,24,25,26,27].